Great West Life Assurance CO Kymera Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $58 Billion
- Q4 2024
A detailed history of Great West Life Assurance CO transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 10,491 shares of KYMR stock, worth $389,530. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,491
Previous 10,491
-0.0%
Holding current value
$389,530
Previous $497,000
15.09%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding KYMR
# of Institutions
186Shares Held
65.5MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$255 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$223 Million2.67% of portfolio
-
Wellington Management Group LLP Boston, MA5.31MShares$197 Million0.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$192 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$191 Million3.02% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.03B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...